- Home
- TDG vs ZTS Comparison
TDG vs ZTS Comparison
Compare TDG & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDG
- ZTS
- Stock Information
- Founded
- TDG 1993
- ZTS 1952
- Country
- TDG United States
- ZTS United States
- Employees
- TDG N/A
- ZTS N/A
- Industry
- TDG Military/Government/Technical
- ZTS Biotechnology: Pharmaceutical Preparations
- Sector
- TDG Industrials
- ZTS Health Care
- Exchange
- TDG Nasdaq
- ZTS Nasdaq
- Market Cap
- TDG 72.6B
- ZTS 70.1B
- IPO Year
- TDG 2006
- ZTS 2013
- Fundamental
- Price
- TDG $1,330.36
- ZTS $160.07
- Analyst Decision
- TDG Buy
- ZTS Strong Buy
- Analyst Count
- TDG 18
- ZTS 9
- Target Price
- TDG $1,478.61
- ZTS $217.56
- AVG Volume (30 Days)
- TDG 253.2K
- ZTS 4.1M
- Earning Date
- TDG 05-06-2025
- ZTS 05-01-2025
- Dividend Yield
- TDG 5.64%
- ZTS 1.25%
- EPS Growth
- TDG 20.43
- ZTS 7.89
- EPS
- TDG 28.37
- ZTS 5.47
- Revenue
- TDG $8,157,000,000.00
- ZTS $9,256,000,000.00
- Revenue This Year
- TDG $13.05
- ZTS $1.77
- Revenue Next Year
- TDG $8.65
- ZTS $6.60
- P/E Ratio
- TDG $46.91
- ZTS $29.26
- Revenue Growth
- TDG 16.91
- ZTS 8.33
- 52 Week Low
- TDG $1,163.82
- ZTS $144.80
- 52 Week High
- TDG $1,451.32
- ZTS $200.33
- Technical
- Relative Strength Index (RSI)
- TDG 49.23
- ZTS 40.34
- Support Level
- TDG $1,304.79
- ZTS $165.22
- Resistance Level
- TDG $1,353.57
- ZTS $177.00
- Average True Range (ATR)
- TDG 31.44
- ZTS 4.66
- MACD
- TDG -3.13
- ZTS -0.42
- Stochastic Oscillator
- TDG 43.96
- ZTS 2.78
About TDG Transdigm Group Incorporated
TransDigm manufactures and services a diverse set of specialized parts for commercial and military aircraft. The firm organizes itself in three segments: power and control, airframes, and a small non-aviation segment, which serves mostly off-road vehicles and mining equipment. It operates as an acquisitive holding company that focuses its portfolio on firms that make proprietary aerospace products with substantial aftermarket demand. TransDigm regularly employs financial leverage to amplify its operating results.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.